GR3022607T3 - Platinum (II) complex and antitumor agent - Google Patents

Platinum (II) complex and antitumor agent

Info

Publication number
GR3022607T3
GR3022607T3 GR970400293T GR970400293T GR3022607T3 GR 3022607 T3 GR3022607 T3 GR 3022607T3 GR 970400293 T GR970400293 T GR 970400293T GR 970400293 T GR970400293 T GR 970400293T GR 3022607 T3 GR3022607 T3 GR 3022607T3
Authority
GR
Greece
Prior art keywords
carbon atoms
platinum
complex
represent
antitumor agent
Prior art date
Application number
GR970400293T
Other languages
English (en)
Inventor
Go Hata
Tatsuya Kaneko
Hideki Kawai
Masato Mutoh
Hideyuki Hashimoto
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of GR3022607T3 publication Critical patent/GR3022607T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR970400293T 1991-06-10 1997-02-19 Platinum (II) complex and antitumor agent GR3022607T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13802991 1991-06-10

Publications (1)

Publication Number Publication Date
GR3022607T3 true GR3022607T3 (en) 1997-05-31

Family

ID=15212384

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400293T GR3022607T3 (en) 1991-06-10 1997-02-19 Platinum (II) complex and antitumor agent

Country Status (11)

Country Link
US (1) US5348950A (el)
EP (1) EP0518645B1 (el)
JP (1) JPH05178873A (el)
KR (1) KR960010017B1 (el)
AT (1) ATE147747T1 (el)
CA (1) CA2070497C (el)
DE (1) DE69216693T2 (el)
DK (1) DK0518645T3 (el)
ES (1) ES2096721T3 (el)
GR (1) GR3022607T3 (el)
TW (1) TW221443B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0704453A4 (en) * 1994-04-19 1998-07-29 Toray Industries NEW PLATINUM (II) COMPLEX AND MEDICINE AGAINST MALIGNE TUMORS
US6316652B1 (en) * 1995-06-06 2001-11-13 Kosta Steliou Drug mitochondrial targeting agents
US8048870B2 (en) * 2005-01-11 2011-11-01 Batarseh Kareem I Apoptosis-inducing antineoplastic silver (I) coordination complexes
DE102005047308A1 (de) * 2005-09-30 2007-04-05 Martin-Luther-Universität Halle-Wittenberg Platin(II)Verbindungen aus 2-substituierten Propan-1,3-diaminen zur Verwendung als Chemotherapeutikum

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980347A (en) * 1986-10-15 1990-12-25 Toray Industries Platinum complex, process for preparing same and antitumor agent
US4912100A (en) * 1986-10-15 1990-03-27 Toray Industries, Inc. Platinum complex, process for preparing same and antitumor agent
EP0341318A4 (en) * 1987-11-11 1990-10-10 Toray Industries, Inc. Novel platinum (ii) complex, process for preparing the same, and therapeutic agent for malignant tumor
EP0345356A4 (en) * 1987-11-11 1990-10-10 Toray Industries, Inc. Platinum complex and therapeutic agent for malignant tumor
JPH01313488A (ja) * 1988-06-13 1989-12-18 Toray Ind Inc 新規白金含有化合物および悪性腫瘍治療剤
EP0457921B1 (en) * 1989-12-12 1996-10-09 Toray Industries, Inc. Novel platinum (ii) complex and drug for treating malignant tumor

Also Published As

Publication number Publication date
DK0518645T3 (da) 1997-02-03
ES2096721T3 (es) 1997-03-16
EP0518645A1 (en) 1992-12-16
CA2070497A1 (en) 1992-12-11
US5348950A (en) 1994-09-20
EP0518645B1 (en) 1997-01-15
TW221443B (el) 1994-03-01
DE69216693T2 (de) 1997-05-07
KR960010017B1 (ko) 1996-07-25
DE69216693D1 (de) 1997-02-27
ATE147747T1 (de) 1997-02-15
CA2070497C (en) 1999-05-25
KR930000529A (ko) 1993-01-15
JPH05178873A (ja) 1993-07-20

Similar Documents

Publication Publication Date Title
NZ298296A (en) Imidazo[4,5-c]quinoline amines; medicaments to induce interferon biosynthesis
MY108261A (en) Water soluble camptothecin derivatives
CA2085345A1 (en) Pyrimidine nucleoside derivatives
KR940005534A (ko) 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제
SE7704783L (sv) Medel for separationsendamal och forfarande for dess framstellning
ATE408595T1 (de) Verbindungen, aus der verbindung hergestelltes polymer und das polymer enthaltende mischung
GR3022607T3 (en) Platinum (II) complex and antitumor agent
HUT53376A (en) Process for producing c63-amide derivatives of 34-de(acetyl-glycosaminyl)-34-deoxy-theicoplanin
NO940026D0 (no) Mono- og bis alkylamino-antra-cykliner
FR2655039B1 (fr) Synthese des bromures de perfluoroalkyle.
ATE127492T1 (de) Für photovernetzungsprozesse geeignete carbonylgruppenhaltige polyphosphazenderivate.
DE59712902D1 (de) Neue aminoalkoholderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel und reagenzien
DK0390138T3 (da) Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel
PT80582B (en) Process for preparing nivel 4-amino-butanoic acid derivatives
DE68911095T2 (de) Antitumor-Substanz, Verfahren zu deren Herstellung und diese enthaltende Antikrebsmittel.